Emmanuel Guardiola

1.8k total citations
36 papers, 726 citations indexed

About

Emmanuel Guardiola is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emmanuel Guardiola has authored 36 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emmanuel Guardiola's work include Head and Neck Cancer Studies (11 papers), Ovarian cancer diagnosis and treatment (9 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). Emmanuel Guardiola is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Ovarian cancer diagnosis and treatment (9 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). Emmanuel Guardiola collaborates with scholars based in France, Belgium and Spain. Emmanuel Guardiola's co-authors include Xavier Pivot, M. Schneider, F Démard, L. Chaigneau, G. Milano, Nicolas Magné, G. Poissonnet, O. Dassonville, René‐Jean Bensadoun and Pierre Yves Marcy and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Emmanuel Guardiola

36 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Guardiola France 18 369 241 240 232 108 36 726
Olivier Capitain France 15 535 1.4× 269 1.1× 114 0.5× 160 0.7× 115 1.1× 59 826
T.D. Nguyen France 11 364 1.0× 421 1.7× 129 0.5× 193 0.8× 45 0.4× 25 778
Gerd Wegener Germany 20 385 1.0× 477 2.0× 140 0.6× 749 3.2× 298 2.8× 49 1.4k
Marie‐Christine Kaminsky France 15 527 1.4× 191 0.8× 215 0.9× 198 0.9× 100 0.9× 40 846
Lionel Duck Belgium 11 490 1.3× 279 1.2× 64 0.3× 313 1.3× 85 0.8× 33 837
E. Sandberg Denmark 10 382 1.0× 163 0.7× 90 0.4× 221 1.0× 60 0.6× 17 749
T F Pajak United States 17 340 0.9× 261 1.1× 260 1.1× 279 1.2× 76 0.7× 27 878
C. Norman Coleman United States 15 226 0.6× 241 1.0× 66 0.3× 140 0.6× 86 0.8× 25 780
Kazım Uygun Türkiye 15 312 0.8× 215 0.9× 50 0.2× 155 0.7× 112 1.0× 56 683
S. Bourdin France 15 326 0.9× 432 1.8× 214 0.9× 264 1.1× 81 0.8× 40 887

Countries citing papers authored by Emmanuel Guardiola

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Guardiola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Guardiola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Guardiola more than expected).

Fields of papers citing papers by Emmanuel Guardiola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Guardiola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Guardiola. The network helps show where Emmanuel Guardiola may publish in the future.

Co-authorship network of co-authors of Emmanuel Guardiola

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Guardiola. A scholar is included among the top collaborators of Emmanuel Guardiola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Guardiola. Emmanuel Guardiola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trédan, Olivier, Philippe Follana, Isabelle Moullet, et al.. (2016). A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study. Annals of Oncology. 27(6). 1020–1029. 19 indexed citations
2.
Guardiola, Emmanuel, et al.. (2013). Experience of multidisciplinary assessment of elderly patients with cancer in a French general hospital during 1year: A new model care study. Journal of Geriatric Oncology. 4(4). 394–401. 15 indexed citations
3.
Guardiola, Emmanuel, Bruno Chauffert, Delphine Delroeux, et al.. (2010). Intraoperative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I study. Anti-Cancer Drugs. 21(3). 320–325. 11 indexed citations
4.
Guardiola, Emmanuel, et al.. (2007). [Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)].. PubMed. 94(10). 907–14. 17 indexed citations
5.
Royer, Bernard, Delphine Delroeux, Emmanuel Guardiola, et al.. (2007). Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer. Cancer Chemotherapy and Pharmacology. 61(3). 415–421. 19 indexed citations
6.
Guardiola, Emmanuel, et al.. (2006). Is there still a role for triple endoscopy as part of staging for head and neck cancer. Archive ouverte UNIGE (University of Geneva). 14(2). 85–88. 21 indexed citations
7.
Fagnoni, Philippe, Samuel Limat, L. Chaigneau, et al.. (2006). Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancer. Supportive Care in Cancer. 14(10). 1030–1037. 9 indexed citations
8.
Pivot, Xavier, Nicolas Magné, Emmanuel Guardiola, et al.. (2005). Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer. Oral Oncology. 41(3). 320–327. 39 indexed citations
9.
Royer, Bernard, Emmanuel Guardiola, Guillaume Hoizey, et al.. (2005). Serum and intraperitoneal pharmacokinetics of cisplatin within intraoperative intraperitoneal chemotherapy: influence of protein binding. Anti-Cancer Drugs. 16(9). 1009–1016. 37 indexed citations
10.
Guardiola, Emmanuel, X. Pivot, O. Dassonville, et al.. (2004). Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?. Cancer. 101(9). 2028–2033. 42 indexed citations
11.
Guardiola, Emmanuel, Frédéric Peyrade, L. Chaigneau, et al.. (2004). Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer. European Journal of Cancer. 40(14). 2071–2076. 82 indexed citations
12.
Guardiola, Emmanuel, et al.. (2003). Les récepteurs à Epidermal Growth Factor (REGF), une nouvelle cible thérapeutique. Cancer/Radiothérapie. 7(3). 195–199. 9 indexed citations
13.
Etienne, M C, F. Léger, Xavier Pivot, et al.. (2003). Pharmacokinetics of low-dose carboplatin and applicability of a method of calculation for estimating individual drug clearance. Annals of Oncology. 14(4). 643–647. 9 indexed citations
14.
Pivot, Xavier, Emmanuel Chamorey, Emmanuel Guardiola, et al.. (2003). Phase I and pharmacokinetic study of the association of capecitabine–cisplatin in head and neck cancer patients. Annals of Oncology. 14(10). 1578–1586. 41 indexed citations
15.
François, Éric, et al.. (2002). Palliative 5-Fluorouracil-Based Chemotherapy for Advanced Colorectal Cancer in the Elderly. American Journal of Clinical Oncology. 25(2). 126–130. 32 indexed citations
16.
Guardiola, Emmanuel, et al.. (2001). Combination of Cisplatin-Doxorubicin-Cyclophosphamide in Adenocarcinoma of Unknown Primary Site. American Journal of Clinical Oncology. 24(4). 372–375. 18 indexed citations
17.
Magné, Nicolas, Pierre Yves Marcy, Emmanuel Chamorey, et al.. (2001). Concomitant twice‐a‐day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long‐term quality of life analysis. Head & Neck. 23(8). 678–682. 48 indexed citations
18.
Magné, Nicolas, Xavier Pivot, René‐Jean Bensadoun, et al.. (2001). The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy. European Journal of Cancer. 37(17). 2169–2177. 45 indexed citations
19.
Pivot, Xavier, L. Cals, Didier Cupissol, et al.. (2000). Phase II Trial of a Paclitaxel-Carboplatin Combination in Recurrent Squamous Cell Carcinoma of the Head and Neck. Oncology. 60(1). 66–71. 33 indexed citations
20.
Pivot, Xavier, Emmanuel Guardiola, M C Etienne, et al.. (2000). An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia. European Journal of Cancer. 36(7). 852–857. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Capitain Breakdown of academic impact, for papers by T.D. Nguyen Breakdown of academic impact, for papers by Gerd Wegener Breakdown of academic impact, for papers by Marie‐Christine Kaminsky Breakdown of academic impact, for papers by Lionel Duck Breakdown of academic impact, for papers by E. Sandberg Breakdown of academic impact, for papers by T F Pajak Breakdown of academic impact, for papers by C. Norman Coleman Breakdown of academic impact, for papers by Kazım Uygun Breakdown of academic impact, for papers by S. Bourdin
Rankless by CCL
2026